Our Consumer Healthcare business develops and markets a range of products based around the four category areas of: Wellness, Oral health, Skin health and Nutrition.
On 02 March 2015 we completed a three-part transaction with Novartis which reshapes our business. We have combined our Consumer Healthcare business with Novartis’s to create one of the world’s largest Consumer Healthcare companies, with number one positions in specialist oral health and over-the-counter (OTC) medicines across 36 markets and leading positions in skin health and family nutrition. More information to follow.
We have a Consumer Healthcare portfolio of well-known global brands including: Aquafresh, Sensodyne, Poligrip, Tums, Breathe Right, Panadol, Contac, Eno, Horlicks, Scott's and NiQuitin.
In 2014, the Consumer Healthcare business accounted for £4.3bn, or 19%, of GSK’s total turnover. Our brands are available in over 100 countries, with more than half of the business’s sales coming from our top-selling brands.
Sales by category (2014)
Today, people are taking an increasingly active role in managing their own health. This is being fuelled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets where consumers are seeking more affordable and accessible products.
Consumer healthcare products are dependent on brand loyalty and trademark protection. Some of our heritage brands such as Horlicks and Eno are more than 140 years old but continue to be popular today.
Our strategy is to combine our pharmaceutical capabilities, scientific expertise and values with the strengths of the Fast Moving Consumer Goods (FMCG) world, such as consumer insight, speed and brand focus to become the best Fast Moving Consumer Healthcare Company.
Innovation and speed to market are critical in the FMCG industry and provide us with a significant opportunity to meet the changing consumer’s needs.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.